Ameritas Investment Company’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20
Closed -$884 744
2021
Q1
$884 Buy
+20
New +$755 ﹤0.01% 2080
2020
Q2
Sell
-8
Closed 350
2020
Q1
$0 Buy
+8
New +$161 ﹤0.01% 1750
2019
Q4
Sell
-5
Closed 845
2019
Q3
$0 Buy
+5
New +$114 ﹤0.01% 1631
2019
Q2
Sell
-37
Closed 235
2019
Q1
$0 Sell
37
-155
-81% -$2.71K ﹤0.01% 938
2018
Q4
$3K Buy
+192
New +$4.97K ﹤0.01% 1304

Other funds holding ADNT

Ameritas Investment Company's ADNT Position: Q2 2021 in Review

Ameritas Investment Company sold out of Adient (ADNT) in Q2 2021, closing a stake of 20 shares — an estimated $884 sold.

Ameritas Investment Company first reported a position in ADNT in Q4 2018 and held it in 5 quarters. The position peaked at $3K in Q4 2018. 290 funds tracked by Wall St. Rank hold ADNT as of Q2 2021.

  • Ameritas Investment Company reported no remaining Adient position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 20 Adient shares in Q2 2021, an estimated $884.
  • Ameritas Investment Company first reported a position in Adient in Q4 2018 and held it in 5 quarters.
  • Ameritas Investment Company's Adient position peaked at $3K in Q4 2018.
  • 290 funds tracked by Wall St. Rank held Adient as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.